PT141

Enhanced intimacy and desire.

PT-141 (Bremelanotide) is a melanocortin receptor agonist that works through the nervous system to enhance sexual desire and function.

How it works

PT-141 activates melanocortin receptors (MC3R/MC4R) in the brain, stimulating sexual arousal pathways directly through the central nervous system rather than the vascular system.

Benefits

• Enhanced sexual desire
• Improved arousal
• Works for both men and women
• Nervous system-mediated (not vascular)

Dosing protocol

1-2mg subcutaneous injection 45 minutes before desired effect. No more than 1 dose per 24 hours, 8 doses per month.

Contraindications

• Uncontrolled hypertension
• Heart disease, stroke, or peripheral vascular disease
• Pregnancy

Compounded medications are not approved by the FDA and have not been reviewed for safety, effectiveness, or quality. Medications only issued when clinically appropriate after provider evaluation.